Novo Nordisk (NVO) is down -19.9%, or -$20.60 to $82.84.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Viking gains ground as Novo Nordisk stumbles, says H.C. Wainwright
- Novo Nordisk falls -20.0%
- BTIG reiterates Buy on Viking Therapeutics after Novo’s CagriSema ‘underwhelms’
- Novo Nordisk (NYSE:NVO) Slides as Weight-Loss Drug Trial Misses Expectations
- Morning Movers: Lilly rises, Novo Nordisk falls following CagriSema trial data